Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Iron chelation and multiple sclerosis.
Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.
Strategies used by individuals with multiple sclerosis and with mild disability to maintain dynamic stability during a steering task.
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs.
Age-related Shift in Neural Complexity Related to Task Performance and Physical Activity.
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.
Commentary on 'Disability outcome measures in multiple sclerosis clinical trials'
Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review.
MRI relaxation in the presence of fictitious fields correlates with myelin content in normal rat brain.
Regulation of the vitamin D receptor gene by environment, genetics and epigenetics.
Headache in multiple sclerosis and autoimmune disorders.
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.
Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta.
Natalizumab treatment for multiple sclerosis.
Deep breathing exercises with positive expiratory pressure in patients with multiple sclerosis - a randomized controlled trial.
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Mitochondrial DNA sequence variation in multiple sclerosis.
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial.
Autoantigens and autoantibodies in multiple sclerosis.
Hydration status substantially affects chronic cerebrospinal venous insufficiency assessments.
Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
New and emerging immune-targeted drugs for the treatment of multiple sclerosis.
[Nosology and etiologies of acute longitudinally extensive transverse myelitis.]
A changing treatment landscape for multiple sclerosis: challenges and opportunities.
Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci.

Pages